Masimo Corp (MASI) 21.84 $MASI
Philips posts 3rd quarter loss
AP - Mon Oct 20, 1:55AM CDT
AMSTERDAM (AP) — Royal Philips NV, the world's largest lighting maker, has reported a 104 million-euro ($132 million) loss for the third quarter, mostly due to a one-off charge after losing a patent infringement lawsuit against Masimo Corp. of the U.S.
MASI: 21.84 (+0.14), PHG: 27.42 (+0.04)
Masimo to Report Third Quarter 2014 Financial Results After Market Close on Wednesday, October 29th
Marketwired - Fri Oct 17, 8:01AM CDT
Masimo (NASDAQ: MASI) announced today that it will release financial results for the third quarter ended September 27, 2014, after the market closes on Wednesday, October 29, 2014. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive Officer, and Mark P. de Raad, Executive Vice President and Chief Financial Officer.
MASI: 21.84 (+0.14)
Two New Clinical Studies Show Masimo Noninvasive Hemoglobin (SpHb(R)) Demonstrated Similar Precision as Hemoglobin From Point of Care Devices
Marketwired - Thu Oct 16, 7:05AM CDT
Masimo (NASDAQ: MASI) announced two new studies today that showed that noninvasive hemoglobin (SpHb(R)) demonstrated similar accuracy as hemoglobin measured by invasive hemoglobin analyzers when both SpHb and the invasive hemoglobin analyzer were compared to laboratory hematology analyzer.
MASI: 21.84 (+0.14)
Downtrend Call Working As Masimo Stock Falls 18.0% (MASI)
Comtex SmarTrend(R) - Wed Oct 15, 5:38PM CDT
SmarTrend identified a Downtrend for Masimo (NASDAQ:MASI) on April 8th, 2014 at $26.46. In approximately 6 months, Masimo has returned 17.97% as of today's recent price of $21.70.
MASI: 21.84 (+0.14)
New Clinical Study Presented at the American Society of Anesthesiologists Annual Meeting Shows Benefit of Oxygen Reserve Index(TM), ORI(TM)
Marketwired - Wed Oct 15, 4:02PM CDT
Masimo (NASDAQ: MASI) announced today that a new clinical study evaluating Masimo's latest noninvasive patient monitoring parameter, Oxygen Reserve Index ORI, showed that ORI can provide advanced warning of potential hypoxia and may help clinicians optimize oxygenation before and during prolonged intubation.(1)
MASI: 21.84 (+0.14)
Retrospective Study of Enhanced Recovery After Surgery Program for Patients Undergoing Colorectal Surgery, Which Included Fluid Therapy Tailored to Masimo's PVI(R), Showed Reduced Length of Stay and Cost Savings
Marketwired - Tue Oct 14, 7:07AM CDT
Masimo (NASDAQ: MASI) announced today the results of a retrospective study of an Enhanced Recovery After Surgery (ERAS) program in colorectal surgery patients, which included Masimo's PVI(R) monitoring.(1) The ERAS program, which included fluid therapy tailored to PVI, resulted in reduced length of hospital stay, significantly reduced hospital costs, lower fluid administration, lower morphine administration, and earlier return of bowl function. The study was presented at the American Society of Anesthesiologists (ASA) Annual Meeting in New Orleans, the largest gathering of anesthesiologists in the world.
MASI: 21.84 (+0.14)
Newborn Foundation Bestows Masimo CEO Joe Kiani With the Hubert H. Humphrey 'Dawn of Life' Award
Marketwired - Mon Oct 13, 7:02PM CDT
The Newborn Foundation presented Joe Kiani, founder, CEO and Chairman of the Board of Masimo (NASDAQ: MASI), with the Hubert H. Humphrey "Dawn of Life" Award at its gala Friday night in Minneapolis, Minn., an honor previously reserved for members of Congress.
MASI: 21.84 (+0.14)
Masimo Announces CE Mark of Eve(TM) Newborn Screening Application for Radical-7, an Intuitive Software Feature to Help Clinicians More Effectively Screen for Critical Congenital Heart Disease
Marketwire Canada - Fri Oct 10, 7:03AM CDT
Masimo (NASDAQ: MASI), maker of breakthrough Masimo SET(R) Measure-through Motion and Low Perfusion(TM) Pulse Oximetry, today announced the CE Mark of Eve(TM) Newborn Screening Software Application- for Radical-7(R) Pulse CO-Oximeters. Eve is designed to help clinicians more effectively and efficiently screen newborns for critical congenital heart disease (CCHD).
MASI: 21.84 (+0.14)
Masimo Gets CE Mark Approval for 11th Rainbow Parameter - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 08, 12:50PM CDT
Masimo Corporation's (MASI) Oxygen Reserve Index (ORI) is the first non-invasive and continuous parameter of its kind which provides an insight into patients' oxygen reserve when they are receiving supplemental oxygen.
GE: 25.45 (+0.42), MASI: 21.84 (+0.14), OPK: 8.39 (+0.03), ERB: 2.76 (-0.01)
Masimo Announces CE Mark of the 11th Rainbow(R) Parameter-ORI(TM), Oxygen Reserve Index(TM)
Marketwire Canada - Tue Oct 07, 2:14PM CDT
Masimo (NASDAQ: MASI) today announced CE Mark and limited market release of Oxygen Reserve Index (ORI(TM)), the first noninvasive and continuous parameter of its kind to provide insight into a patient's oxygen reserve when they are receiving supplemental oxygen. With ORI, Masimo's rainbow SET(R) Pulse CO-Oximeters with the latest MX-5 circuit board can now measure an unprecedented 11 parameters(1) through its noninvasive optical rainbow(R) sensor technology.
MASI: 21.84 (+0.14)
Masimo Announces CE Mark of the 11th Rainbow(R) Parameter - ORI(TM), Oxygen Reserve Index(TM)
Marketwire - Tue Oct 07, 2:14PM CDT
Masimo (NASDAQ: MASI) today announced CE Mark and limited market release of Oxygen Reserve Index (ORI(TM)), the first noninvasive and continuous parameter of its kind to provide insight into a patient's oxygen reserve when they are receiving supplemental oxygen. With ORI, Masimo's rainbow SET(R) Pulse CO-Oximeters with the latest MX-5 circuit board can now measure an unprecedented 11 parameters(1) through its noninvasive optical rainbow(R) sensor technology.
MASI: 21.84 (+0.14)
Nasdaq stocks posting largest percentage increases
AP - Thu Oct 02, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
KNDI: 13.09 (-0.36), BCRX: 11.37 (-0.23), MASI: 21.84 (+0.14), ANY: 5.68 (+0.01), BSET: 17.05 (+0.17), ADHD: 5.12 (-0.20), TKMR: 17.98 (-0.63), TKM.TO: 20.17 (-0.82), DMRC: 24.81 (+0.58), AXDX: 24.38 (+0.24), ANGI: 8.28 (-0.40), RTRX: 9.49 (-0.11), LAKE: 14.94 (+0.01), RTGN: 4.94 (+0.35)
Market Maker Surveillance Report. MSB, CGA, NYT, LAKE, MASI, ARDX, Winning Stocks With Lowest Price Friction For Wednesday, October 1st 2014
M2 - Thu Oct 02, 4:21AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 4709 companies with "abnormal" market making, 1203 companies with positive Friction Factors and 4063 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Wednesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Mesabi Trust (NYSE:MSB), China Green Agriculture Inc (NYSE:CGA), New York Times Co (NYSE:NYT), Lakeland Industries Inc (NASDAQ:LAKE), MASIMO CORPORATION (NASDAQ:MASI), (NASDAQ:ARDX). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
CGA: 2.32 (-0.03), MASI: 21.84 (+0.14), LAKE: 14.94 (+0.01), NYT: 12.90 (+0.43), ARDX: 21.16 (+1.18), MSB: 20.11 (+0.58)
Philips loses $467M patent suit to US competitor
AP - Thu Oct 02, 2:51AM CDT
AMSTERDAM (AP) — Royal Philips NV says it will book a $467 million (366 million-euro) charge in the third quarter after losing a patent lawsuit to smaller U.S. competitor Masimo Corp.
PHG: 27.42 (+0.04), MASI: 21.84 (+0.14)
Market News: Angie's List, Masimo Corporation, Portola Pharmaceuticals
at The Street - Wed Oct 01, 3:58PM CDT
David Tepper of Appaloosa Management said the 'U.S. economy is pretty good, stocks are not at high multiples right now"The stock markets in the United States continued to decline as investors were d...
PTLA: 26.88 (-0.33), MASI: 21.84 (+0.14), ANGI: 8.28 (-0.40)
Masimo SET Pulse Oximetry at New York's Mercy Hospital - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 01, 12:10PM CDT
Masimo Corporation's (MASI) Patient SafetyNet system along with SET technology presents the opportunity to enhance patient safety, improve outcomes, and reduce costs by avoiding preventable patient transfers to the ICU.
ATEC: 1.49 (unch), MASI: 21.84 (+0.14), EW: 105.81 (+3.94), ERB: 2.76 (-0.01)
Philips posts 3rd quarter loss
AP - Mon Oct 20, 1:55AM CDT
AMSTERDAM (AP) — Royal Philips NV, the world's largest lighting maker, has reported a 104 million-euro ($132 million) loss for the third quarter, mostly due to a one-off charge after losing a patent infringement lawsuit against Masimo Corp. of the U.S.
MASI: 21.84 (+0.14), PHG: 27.42 (+0.04)
Masimo to Report Third Quarter 2014 Financial Results After Market Close on Wednesday, October 29th
Marketwired - Fri Oct 17, 8:01AM CDT
Masimo (NASDAQ: MASI) announced today that it will release financial results for the third quarter ended September 27, 2014, after the market closes on Wednesday, October 29, 2014. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive Officer, and Mark P. de Raad, Executive Vice President and Chief Financial Officer.
MASI: 21.84 (+0.14)
Two New Clinical Studies Show Masimo Noninvasive Hemoglobin (SpHb(R)) Demonstrated Similar Precision as Hemoglobin From Point of Care Devices
Marketwired - Thu Oct 16, 7:05AM CDT
Masimo (NASDAQ: MASI) announced two new studies today that showed that noninvasive hemoglobin (SpHb(R)) demonstrated similar accuracy as hemoglobin measured by invasive hemoglobin analyzers when both SpHb and the invasive hemoglobin analyzer were compared to laboratory hematology analyzer.
MASI: 21.84 (+0.14)
Downtrend Call Working As Masimo Stock Falls 18.0% (MASI)
Comtex SmarTrend(R) - Wed Oct 15, 5:38PM CDT
SmarTrend identified a Downtrend for Masimo (NASDAQ:MASI) on April 8th, 2014 at $26.46. In approximately 6 months, Masimo has returned 17.97% as of today's recent price of $21.70.
MASI: 21.84 (+0.14)
New Clinical Study Presented at the American Society of Anesthesiologists Annual Meeting Shows Benefit of Oxygen Reserve Index(TM), ORI(TM)
Marketwired - Wed Oct 15, 4:02PM CDT
Masimo (NASDAQ: MASI) announced today that a new clinical study evaluating Masimo's latest noninvasive patient monitoring parameter, Oxygen Reserve Index ORI, showed that ORI can provide advanced warning of potential hypoxia and may help clinicians optimize oxygenation before and during prolonged intubation.(1)
MASI: 21.84 (+0.14)
Retrospective Study of Enhanced Recovery After Surgery Program for Patients Undergoing Colorectal Surgery, Which Included Fluid Therapy Tailored to Masimo's PVI(R), Showed Reduced Length of Stay and Cost Savings
Marketwired - Tue Oct 14, 7:07AM CDT
Masimo (NASDAQ: MASI) announced today the results of a retrospective study of an Enhanced Recovery After Surgery (ERAS) program in colorectal surgery patients, which included Masimo's PVI(R) monitoring.(1) The ERAS program, which included fluid therapy tailored to PVI, resulted in reduced length of hospital stay, significantly reduced hospital costs, lower fluid administration, lower morphine administration, and earlier return of bowl function. The study was presented at the American Society of Anesthesiologists (ASA) Annual Meeting in New Orleans, the largest gathering of anesthesiologists in the world.
MASI: 21.84 (+0.14)
Newborn Foundation Bestows Masimo CEO Joe Kiani With the Hubert H. Humphrey 'Dawn of Life' Award
Marketwired - Mon Oct 13, 7:02PM CDT
The Newborn Foundation presented Joe Kiani, founder, CEO and Chairman of the Board of Masimo (NASDAQ: MASI), with the Hubert H. Humphrey "Dawn of Life" Award at its gala Friday night in Minneapolis, Minn., an honor previously reserved for members of Congress.
MASI: 21.84 (+0.14)
Masimo Announces CE Mark of Eve(TM) Newborn Screening Application for Radical-7, an Intuitive Software Feature to Help Clinicians More Effectively Screen for Critical Congenital Heart Disease
Marketwire Canada - Fri Oct 10, 7:03AM CDT
Masimo (NASDAQ: MASI), maker of breakthrough Masimo SET(R) Measure-through Motion and Low Perfusion(TM) Pulse Oximetry, today announced the CE Mark of Eve(TM) Newborn Screening Software Application- for Radical-7(R) Pulse CO-Oximeters. Eve is designed to help clinicians more effectively and efficiently screen newborns for critical congenital heart disease (CCHD).
MASI: 21.84 (+0.14)
Masimo Gets CE Mark Approval for 11th Rainbow Parameter - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 08, 12:50PM CDT
Masimo Corporation's (MASI) Oxygen Reserve Index (ORI) is the first non-invasive and continuous parameter of its kind which provides an insight into patients' oxygen reserve when they are receiving supplemental oxygen.
GE: 25.45 (+0.42), MASI: 21.84 (+0.14), OPK: 8.39 (+0.03), ERB: 2.76 (-0.01)
Masimo Announces CE Mark of the 11th Rainbow(R) Parameter-ORI(TM), Oxygen Reserve Index(TM)
Marketwire Canada - Tue Oct 07, 2:14PM CDT
Masimo (NASDAQ: MASI) today announced CE Mark and limited market release of Oxygen Reserve Index (ORI(TM)), the first noninvasive and continuous parameter of its kind to provide insight into a patient's oxygen reserve when they are receiving supplemental oxygen. With ORI, Masimo's rainbow SET(R) Pulse CO-Oximeters with the latest MX-5 circuit board can now measure an unprecedented 11 parameters(1) through its noninvasive optical rainbow(R) sensor technology.
MASI: 21.84 (+0.14)
Masimo Announces CE Mark of the 11th Rainbow(R) Parameter - ORI(TM), Oxygen Reserve Index(TM)
Marketwire - Tue Oct 07, 2:14PM CDT
Masimo (NASDAQ: MASI) today announced CE Mark and limited market release of Oxygen Reserve Index (ORI(TM)), the first noninvasive and continuous parameter of its kind to provide insight into a patient's oxygen reserve when they are receiving supplemental oxygen. With ORI, Masimo's rainbow SET(R) Pulse CO-Oximeters with the latest MX-5 circuit board can now measure an unprecedented 11 parameters(1) through its noninvasive optical rainbow(R) sensor technology.
MASI: 21.84 (+0.14)
Nasdaq stocks posting largest percentage increases
AP - Thu Oct 02, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
KNDI: 13.09 (-0.36), BCRX: 11.37 (-0.23), MASI: 21.84 (+0.14), ANY: 5.68 (+0.01), BSET: 17.05 (+0.17), ADHD: 5.12 (-0.20), TKMR: 17.98 (-0.63), TKM.TO: 20.17 (-0.82), DMRC: 24.81 (+0.58), AXDX: 24.38 (+0.24), ANGI: 8.28 (-0.40), RTRX: 9.49 (-0.11), LAKE: 14.94 (+0.01), RTGN: 4.94 (+0.35)
Market Maker Surveillance Report. MSB, CGA, NYT, LAKE, MASI, ARDX, Winning Stocks With Lowest Price Friction For Wednesday, October 1st 2014
M2 - Thu Oct 02, 4:21AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 4709 companies with "abnormal" market making, 1203 companies with positive Friction Factors and 4063 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Wednesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Mesabi Trust (NYSE:MSB), China Green Agriculture Inc (NYSE:CGA), New York Times Co (NYSE:NYT), Lakeland Industries Inc (NASDAQ:LAKE), MASIMO CORPORATION (NASDAQ:MASI), (NASDAQ:ARDX). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
CGA: 2.32 (-0.03), MASI: 21.84 (+0.14), LAKE: 14.94 (+0.01), NYT: 12.90 (+0.43), ARDX: 21.16 (+1.18), MSB: 20.11 (+0.58)
Philips loses $467M patent suit to US competitor
AP - Thu Oct 02, 2:51AM CDT
AMSTERDAM (AP) — Royal Philips NV says it will book a $467 million (366 million-euro) charge in the third quarter after losing a patent lawsuit to smaller U.S. competitor Masimo Corp.
PHG: 27.42 (+0.04), MASI: 21.84 (+0.14)
Market News: Angie's List, Masimo Corporation, Portola Pharmaceuticals
at The Street - Wed Oct 01, 3:58PM CDT
David Tepper of Appaloosa Management said the 'U.S. economy is pretty good, stocks are not at high multiples right now"The stock markets in the United States continued to decline as investors were d...
PTLA: 26.88 (-0.33), MASI: 21.84 (+0.14), ANGI: 8.28 (-0.40)
Masimo SET Pulse Oximetry at New York's Mercy Hospital - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 01, 12:10PM CDT
Masimo Corporation's (MASI) Patient SafetyNet system along with SET technology presents the opportunity to enhance patient safety, improve outcomes, and reduce costs by avoiding preventable patient transfers to the ICU.
ATEC: 1.49 (unch), MASI: 21.84 (+0.14), EW: 105.81 (+3.94), ERB: 2.76 (-0.01)
